BIIB — BIOGEN INC

Ownership history in EntryPoint Capital, LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in BIOGEN INC (BIIB). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.2% (2025 Q1)
Avg. % of fund
0.15%
First filed
2024 Q1
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 3,319 +258 +8.4% 0.18% $465K $140.08
2025 Q2 REDUCED 3,061 -118 -3.7% 0.19% $384K $125.59
2025 Q1 ADDED 3,179 +1,540 +94.0% 0.20% $435K $136.84
2024 Q4 ADDED 1,639 +55 +3.5% 0.11% $251K $152.92
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    BIIB price (monthly, adj. close)

Other funds also holding BIIB

As of 2025 Q4 — sorted by position size

Palo Alto Investors LP 3Y 7Y 4.5% BRIDGER MANAGEMENT, LLC 3Y 7Y 4.08% Patient Capital Management, LLC 3Y 3.92% SECTOR GAMMA AS 3Y 7Y 3.43% Hillman Capital Management, Inc. 3Y 7Y 3.38% SPHERA FUNDS MANAGEMENT LTD. 3Y 7Y 3.22% Privium Fund Management B.V. 3Y 2.38% Logos Global Management LP 3Y 2.13% Orion Investment Co 2.11% PRIMECAP MANAGEMENT CO/CA/ 3Y 7Y 1.97%
← Back to EntryPoint Capital, LLC Holdings